Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...
Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...
GlaxoSmithKline share price has surged more than 36% in two sessions after the announcement of Q3 results. The stock has ...
The company posted a multifold jump per cent in consolidated net profit to Rs 230 crore as compared to Rs 46 crore a year ago ...
NAFDAC has uncovered counterfeit medicines and unregistered narcotics during its enforcement operation at the Idumota open ...
Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90.
The Punch on MSN7h
PICTORIAL: NAFDAC uncovers counterfeit drugs, expired condoms repackaged for sale at Lagos marketThe National Agency for Food and Drug Administration and Control has made alarming discoveries in its ongoing enforcement ...
Daily Post Nigeria on MSN5h
Nigerian drug agency uncovers expired USAID-donated condoms repackaged for saleThe National Agency for Food and Drug Administration and Control, NAFDAC has uncovered and seized expired condoms that were donated by the United States ...
GlaxoSmithKline Pharmaceuticals shares surged 20% to ₹2,421.30 after a strong Q3FY25 performance, reporting a 400% rise in ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS – Research ...
GlaxoSmithKline Pharmaceuticals' shares surged nearly 16% as net profit rose over five-fold to Rs 229 crore for Q3 2024. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback